Phari

ICD 10 is coming and these are some new codes. Love the sucked into jet engine one

🚨 TIL therapy is finally breaking through in solid tumors New review: Evolving TIL therapy in metastatic melanoma 📊 Visual summary below 🔗 Full article: frontiersin.org/journals/immun… #Oncology #Immunotherapy #Melanoma #CellTherapy #TIL

@timfenske True .. such a great all purpose tool picks up everything from the mundane to anionic IgA paraproteins !

Anyone who has worked with me on inpatient service knows that the Anion Gap is one of my favorite lab tests. So many things it can help diagnose… So imagine how happy I was to meet Dr Emmett, widely credited with popularizing the use of the AG in modern medicine!

Check our viewpoint published @JAMA_current #MedEd Abstract Factory—Research Culture Harming Medical Education The "abstract factory" is destroying medical education. Trainees and junior faculty compete with abstract counts instead of meaningful research. Result: inflated CVs, diluted conferences. We shouldn't celebrate this—you don't need publications to be a great doctor. ➡️jamanetwork.com/journals/jama/… @utswcancer @rajshekharucms @HiraSMian @ManniMD1 @HemOncFellows @ASCOTECAG

Just out in @NEJM Effective therapy of extra medullary relapsed myeloma with teclistamab plus talquetamab (Tec-Tal). RedirecTT-1 #ASH25 @myelomaMD @szusmani @mvmateos 80% response rate. 60% PFS at 12 months. nejm.org/doi/full/10.10…

@qatarairways Thank you 🙏.. for taking care of this

@Phari @Phari Hello, Phari. Thank you for reaching out to us. We would like to extend our sincere apologies for the inconvenience caused. Kindly reach out to us through private message so that we may assist you further.

@qatarairways Your app or website does not allow one to add American FF number to my booking. What is the value of being one world top tier if we cannot add it seamlessly to Qatar bookings and enjoy your one world partnership?

@traveloneworld ..

@Phari @ASTCT Definitely. ASCT, Early or late, must be considered in all transplant eligible patients

BMT @ASTCT .. please note that as front line transplant for myeloma is used less and less we still discuss collection of cells and offer it to patients.

@VincentRK @SurbhiSidanaMD @hhashmi87 @TomBmt133 Doing well.. recovering from the burnout and learning the broad financial and regulatory aspects of drug development that we never got to see as PIs or triallists.

@Phari @SurbhiSidanaMD @hhashmi87 @TomBmt133 How are you?

Here are my Top 5 #ASH25 @ASH_hematology myeloma abstracts. #ASH25VR My Top 5 are based on new data, clinical impact, & methodology with links to the full abstract. Bookmark! Thread with countdown 👇

@VincentRK @SurbhiSidanaMD @hhashmi87 @TomBmt133 Unfortunately this will be a waning option as front line transplant/ cell collection recedes … people with bags in the freezer become a rarity ! Unless we find a way to pay for pheresis and storage

#5 Stem cell boost as treatment for cytopenias after CART. Cindy Varga et al. @SurbhiSidanaMD @hhashmi87 @TomBmt133 Highly effective, safe, and practical. #ASH25 Link: meetings-api.hematology.org/api/abstract/v…

@timfenske @bdermanmd And this approach which we pioneered in 2018 first is our go to when steroids are not working. Early initiation is key .. full series from 2022 jamanetwork.com/journals/jamao…

@bdermanmd I think IT chemo is underutilized for CART neurotox in general. We published this study in 2020 showing that it is effective. ashpublications.org/bloodadvances/…

Cilta-cel associated Parkinsonism remains a challenge. Instead of going right to high dose Cy which can be toxic to circulating CAR T cells, we opted to try intrathecal chemotherapy in 5 consecutive cases. 4/5 pts had a response and 3 complete resolution! IT chemo seemed to be most effective in those with CSF lymphocytosis.

@SewantiLimaye @AACR2025 @VivekSubbiah @ANaingMD @geoff_oxnard @DrHaddadRobert @HeadNeckMD @SGoswamiMDPhD @DrChoueiri Congratulations Aditya and was so great seeing you Sewanti..😊

Thrilled to meet friends @AACR2025 and be inspired by their work! @VivekSubbiah @ANaingMD @geoff_oxnard @DrHaddadRobert @HeadNeckMD @SGoswamiMDPhD @DrChoueiri @Phari

Truly honoured to be @AACR2025 & speak on #Precision in #RareCancers “A view from India”. Amazing to share the stage with the great @Dr_R_Kurzrock and @youngkwangchae #DART ! @UmutDisel @SGoswamiMDPhD thank you for being the audience! 🙏 @RFhospital @OncoAlert @oncodaily

@AACR2025 @VivekSubbiah @ANaingMD @geoff_oxnard @DrHaddadRobert @HeadNeckMD @SGoswamiMDPhD @DrChoueiri @Phari But truly overjoyed and overwhelmed by @AdityaSunavs #OralPresentation #Penpulimab #NPC @Dr_R_Kurzrock @VivekSubbiah @BalazsHalmosMD @ANaingMD @Phari @HeadNeckMD @OncoAlert @oncodaily @OncBrothers #BrotherSisterGoals

From Lab to Startup: Dr. Simrit Parmar on Launching Cellenkos youtu.be/TbYwHukA2Ik?si… via @YouTube The world of startups is hard and filled w challenges. The inspiring journey of @spa718 shows tenacity and perseverance that we can all learn from. My last #HealthcareUnfiltered

Thank you ⁦@anantm⁩ and his colleagues from ⁦@EmoryUniversity⁩ for this must read - excellent review for clinicians on Artificial Intelligence ascopubs.org/doi/10.1200/OP… ⁦@JCOOP_ASCO⁩ ⁦@OncoAlert⁩ ⁦@EthicsdoctorP⁩

⁦@niravshahmd⁩ presenting CD19.20 CAR-T in DLBCL- a phase 2 registration study with POC manufacturing ⁦@MedicalCollege⁩ #tandem25

Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma | Journal for ImmunoTherapy of Cancer ⁦@MCWCancerCenter⁩ ⁦⁦@Chhabra_mayo⁩ ⁦@Phari⁩ jitc.bmj.com/content/13/1/e…